NCT04890561View on ClinicalTrials.gov

A Study to Evaluate Lemborexant in Milk of Healthy Lactating Women

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

May 17, 2021

Primary Completion Date

August 12, 2021

Study Completion Date

August 12, 2021

Conditions

Healthy Volunteers

Interventions

DRUG

Lemborexant

Lemborexant oral tablets.

Trial Locations (1)

89113

PPD Phase 1 Clinic, Las Vegas

All Listed Sponsors

lead

Eisai Inc.

INDUSTRY